Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Singh, Ajaypal

One or more keywords matched the following items that are connected to Singh, Ajaypal

Item Type	Name
Concept	Hemoglobins
Academic Article	The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
Academic Article	Correction of anemia with epoetin alfa in chronic kidney disease.
Academic Article	The target hemoglobin in patients with chronic kidney disease.
Academic Article	Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
Academic Article	The FDA black box for EPO: what should nephrologists do?
Academic Article	Anemia of chronic kidney disease: CHOIR and the FDA.
Academic Article	Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease.
Academic Article	Is it time to reconsider subcutaneous administration of epoetin?
Academic Article	Reducing versus discontinuing erythropoietin at high hemoglobin levels.
Academic Article	Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.
Academic Article	The optimal hemoglobin in dialysis patients- a critical review.
Academic Article	Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
Academic Article	Iron deficiency in non-dialysis chronic kidney disease.
Academic Article	Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.
Academic Article	Hemoglobin target in chronic kidney disease: a pediatric perspective.
Academic Article	The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
Academic Article	Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation.
Academic Article	Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro.
Academic Article	Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
Academic Article	A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Academic Article	A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.
Academic Article	Does TREAT give the boot to ESAs in the treatment of CKD anemia?
Academic Article	The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
Academic Article	Should we keep hemoglobin levels as a viable outcome measure?
Academic Article	Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
Academic Article	What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?
Academic Article	Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
Academic Article	Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents.
Academic Article	Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.
Academic Article	Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Academic Article	Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.
Academic Article	Ferric pyrophosphate citrate (Triferic?) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
Academic Article	A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
Academic Article	Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
Academic Article	Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
Academic Article	Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Academic Article	Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
Academic Article	The ASCEND-ND trial: study design and participant characteristics.
Academic Article	Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
Academic Article	Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials.
Academic Article	Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
Academic Article	The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.
Academic Article	Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.

Search Criteria

Hemoglobins